New York State Common Retirement Fund
LEGN icon

New York State Common Retirement Fund’s Legend Biotech LEGN Stock Holding History

New York State Common Retirement Fund’s Portfolio LEGN Stock Details LEGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$3.91M Sell
135,404
-27,744
-17% -$748K ﹤0.01% 1177
2026
Q1 		$2.95M Hold
163,148
– – ﹤0.01% 1221
2025
Q4 		$3.55M Hold
163,148
– – ﹤0.01% 1167
2025
Q3 		$5.32M Buy
163,148
+44,374
+37% +$1.64M 0.01% 1038
2025
Q2 		$4.22M Buy
118,774
+59,498
+100% +$1.93M 0.01% 1123
2025
Q1 		$2.01M Hold
59,276
– – ﹤0.01% 1377
2024
Q4 		$1.93M Buy
59,276
+39,256
+196% +$1.63M ﹤0.01% 1432
2024
Q3 		$976K Sell
20,020
-818
-4% -$43.6K ﹤0.01% 1682
2024
Q2 		$923K Buy
20,838
+401
+2% +$18.5K ﹤0.01% 1799
2024
Q1 		$1.15M Buy
20,437
+42
+0.2% +$2.53K ﹤0.01% 1711
2023
Q4 		$1.23M Sell
20,395
-9,983
-33% -$633K ﹤0.01% 1689
2023
Q3 		$2.04M Sell
30,378
-31
-0.1% -$2.15K ﹤0.01% 1440
2023
Q2 		$2.1M Sell
30,409
-24,592
-45% -$1.61M ﹤0.01% 1479
2023
Q1 		$2.65M Buy
55,001
+86
+0.2% +$4.21K ﹤0.01% 1422
2022
Q4 		$2.74M Sell
54,915
-12,704
-19% -$615K ﹤0.01% 1478
2022
Q3 		$2.76M Buy
67,619
+2,764
+4% +$130K ﹤0.01% 1450
2022
Q2 		$3.57M Buy
+64,855
New +$2.74M ﹤0.01% 1361

Other funds holding LEGN

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
DM
Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return
SCM
Suvretta Capital Management New York $5.47B AUM 131.34% 1-Year Est. Return
HA
HHLR Advisors Grand Cayman, Cayman Islands $832M AUM 32.38% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Westfield Capital Management
Westfield Capital Management Boston, Massachusetts $30.6B AUM 61.81% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return
KCM
Kynam Capital Management Princeton, New Jersey $1.81B AUM 192.15% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.56% 1-Year Est. Return

New York State Common Retirement Fund's LEGN Position: Q2 2026 in Review

New York State Common Retirement Fund reduced its Legend Biotech (LEGN) stake by 17% in Q2 2026, selling an estimated $748K and leaving 135,404 shares worth $3.91M. The position accounts for ﹤0.01% of the portfolio, ranked #1177.

New York State Common Retirement Fund first reported a position in LEGN in Q2 2022 and has held it in 17 quarters since. The position peaked at $5.32M in Q3 2025. 219 funds tracked by Wall St. Rank hold LEGN as of Q2 2026.

  • New York State Common Retirement Fund held 135,404 shares of Legend Biotech worth $3.91M as of Q2 2026.
  • New York State Common Retirement Fund sold 27,744 Legend Biotech shares in Q2 2026, an estimated $748K.
  • Legend Biotech made up ﹤0.01% of New York State Common Retirement Fund's portfolio in Q2 2026, its #1177 holding.
  • New York State Common Retirement Fund first reported a position in Legend Biotech in Q2 2022 and has held it in 17 quarters since.
  • New York State Common Retirement Fund's Legend Biotech position peaked at $5.32M in Q3 2025.
  • 219 funds tracked by Wall St. Rank held Legend Biotech as of Q2 2026.

Based on New York State Common Retirement Fund's 13F filing for Q2 2026, filed 29 Jul 2026.